Markets
Rezolute, Inc. (RZLT)
RZLTNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$3.65
-0.2200 (-5.68%) today
At the close, Nov 13, 4:00 PM ET. After hours $3.66 –
-5.68% 1D
- Market cap
- $353.54m
- P/E
- –
- EPS, last 4 quarters
- $-0.7600
- Dividend yield
- –
- Day range
- $3.60 to $4.61
- 52-week range
- $1.07 to $11.17
- Average volume
- –
- Previous close
- $3.87
Analysts
8 coveringBuy8 buy, 0 hold, 0 sell
Targets a year out average $10.43, +185.8% from here
$6.00now $3.65$15.00
Earnings
next estimate $-0.1700Next report
Dec 2025
-37.5%
Mar 2026
-23.1%
Jun 2026
-42.9%
Sep 2026
0.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$24.22m | -$17.37m | -$21.56m | -$19.39m |
| Net income | -$22.77m | -$16.17m | -$20.49m | -$18.49m |
News
8 latest- Rezolute Reports Positive Phase 3 Results For Ersodetug; Prices $100M Offering RTTNews · 8 hours ago
- Rezolute, Inc. Outlines Ersodetug Clinical Milestones and Reports $108 million in CashFintel · Oct 30, 2026
- Rezolute Completes Enrollment In Phase 3 UpLIFT Study Of Ersodetug For Tumor Hyperinsulinism RTTNews · Oct 15, 2026
- Cantor Fitzgerald Upgrades Rezolute to Overweight from NeutralFintel · Oct 6, 2026
- FDA Recommends Next Regulatory Step For Rezolute's Ersodetug;Stock Up RTTNews · Oct 5, 2026
- Rezolute Prepares For Potential BLA Filing Of Ersodetug In Congenital HI RTTNews · Oct 5, 2026
- Rezolute Consensus Price Target Increased by 18.70% to $9.28Fintel · Oct 2, 2026
- Craig-Hallum Upgrades Rezolute to Buy from HoldFintel · Sep 29, 2026
The company
Rezolute is a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by any form of hyperinsulinism (HI).
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- rezolutebio.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.